AI assistant
EXELIXIS, INC. — Director's Dealing 2024
Dec 3, 2024
30561_dirs_2024-12-02_6d77615b-261b-4e1b-95c3-4d6d38614b0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-11-27
Reporting Person: Hessekiel Jeffrey (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-27 | Common Stock | M | 129314 | $18.80 | Acquired | 644967 | Direct |
| 2024-11-27 | Common Stock | F | 98908 | $35.93 | Disposed | 546059 | Direct |
| 2024-11-29 | Common Stock | S | 60000 | $36.67 | Disposed | 486059 | Direct |
| 2024-11-29 | Common Stock | G | 15000 | — | Disposed | 471059 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-27 | Option (right to buy) | $18.80 | M | 129314 | Disposed | 2025-09-09 | Common Stock (129314) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 999 | Indirect |
Footnotes
F1: Includes 207,072 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2: Represents a "net exercise" of an outstanding stock option to purchase 129,314 shares, and pursuant to which the Reporting Person received 30,406 shares, of Common Stock. The Issuer withheld 98,908 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on November 27, 2024 of $35.93.
F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.36 to $36.93. Reporting Person undertakes to provide Exelixis, Inc., any security
holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in
footnote 3 to this Form 4.
F4: On November 29, 2024, the Reporting Person gifted 15,000 shares of Common Stock.
F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 26, 2024.
F6: The option, representing the right to purchase a total of 129,314 shares of Common Stock, became fully exercisable on September 10, 2022.